Literature DB >> 1139427

Spindle cell carcinoma of the larynx.

V J Hyams.   

Abstract

A clinicopathologic correlation of 39 cases of a histologically biphasic malignant neoplasm of the larynx is presented. The histologic pattern of this entity was mainly that of a malignant spindle cell process, but a definite squamous cell carcinoma component was evident. Grossly the tumors were usually prominently polypoid. A morphologic transition of the squamous cell carcinomatous element into the spindle cell component was strongly suggested, supporting the contention that this entity is pathogenetically a pleomorphic or spindle cell squamous cell carcinoma. Follow-up information on 20 cases indicated a two-year mortality of 40 per cent, refuting the contention that this entity is of low-grade malignancy. Complete surgical removal of the neoplasm, with or without irradiation, offered the best therapeutic approach. Irradiation alone was unsuccessful.

Entities:  

Mesh:

Year:  1975        PMID: 1139427

Source DB:  PubMed          Journal:  Can J Otolaryngol        ISSN: 0045-5083


  3 in total

1.  Sarcomatoid (spindle cell) carcinoma of the head and neck mucosal region: a clinicopathologic review of 103 cases from a tertiary referral cancer centre.

Authors:  Seethalakshmi Viswanathan; Khaliqur Rahman; Suryawanshi Pallavi; Johari Sachin; Asawari Patil; Pankaj Chaturvedi; Anil D'Cruz; Jaiprakash Agarwal; S V Kane
Journal:  Head Neck Pathol       Date:  2010-08-22

Review 2.  Diagnostically challenging lesions in head and neck pathology.

Authors:  L D Thompson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Clinicopathologic features and outcome of head and neck mucosal spindle cell squamous cell carcinoma.

Authors:  Carlos N Prieto-Granada; Bin Xu; Bayan Alzumaili; Mohamed Rizwan Haroon Al Rasheed; Antoine Eskander; Danny Enepekides; Snehal G Patel; Todd M Stevens; Snjezana Dogan; Ronald Ghossein; Nora Katabi
Journal:  Virchows Arch       Date:  2021-05-12       Impact factor: 4.535

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.